Salta al contenuto principale
Passa alla visualizzazione normale.


Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: Results of EUROCARE-5, a population-based study

  • Autori: Baili P.; Salvo F.D.; Marcos-Gragera R.; Siesling S.; Mallone S.; Santaquilani M.; Micheli A.; Lillini R.; Francisci S.; Hackl M.; Zielonke N.; Oberaigner W.; Eycken E.V.; Henau K.; Valerianova Z.; Dimitrova N.; Sekerija M.; Zvolsky M.; Dusek L.; Storm H.; Engholm G.; Magi M.; Aareleid T.; Malila N.; Seppa K.; Velten M.; Troussard X.; Bouvier V.; Launoy G.; Guizard A.V.; Faivre J.; Bouvier A.M.; Arveux P.; Maynadie M.; Woronoff A.S.; Robaszkiewicz M.; Baldi I.; Monnereau A.; Tretarre B.; Bossard N.; Belot A.; Colonna M.; Molinie F.; Bara S.; Schvartz C.; Lapotre-Ledoux B.; Grosclaude P.; Meyer M.; Stabenow R.; Luttmann S.; Eberle A.; Brenner H.; Nennecke A.; Engel J.; Schubert-Fritschle G.; Kieschke J.; Heidrich J.; Holleczek B.; Katalinic A.; Jonasson J.G.; Tryggvadottir L.; Comber H.; Mazzoleni G.; Bulatko A.; Buzzoni C.; Giacomin A.; Sardo A.S.; Mazzei A.; Ferretti S.; Crocetti E.; Manneschi G.; Gatta G.; Sant M.; Amash H.; Amati C.; Baili P.; Berrino F.; Bonfarnuzzo S.; Botta L.; Salvo F.D.; Foschi R.; Margutti C.; Meneghini E.; Minicozzi P.; Trama A.; Serraino D.; Zucchetto A.; Angelis R.D.; Caldora M.; Capocaccia R.; Carrani E.; Francisci S.; Mallone S.; Pierannunzio D.; Roazzi P.; Rossi S.; Santaquilani M.; Tavilla A.; Pannozzo F.; Natali M.; Bonelli L.; Vercelli M.; Gennaro V.; Ricci P.; Autelitano M.; Randi G.; Ponz De Leon M.; Marchesi C.; Cirilli C.; Fusco M.; Vitale M.F.; Usala M.; Traina A.; Zarcone M.; Vitale F.; Cusimano R.; Michiara M.; Tumino R.; Rossi P.G.; Vicentini M.; Falcini F.; Iannelli A.; Sechi O.; Cesaraccio R.; Piffer S.; Madeddu A.; Tisano F.; Maspero S.; Fanetti A.C.; Zanetti R.; Rosso S.; Candela P.; Scuderi T.; Stracci F.; Rocca A.; Tagliabue G.; Contiero P.; Tos A.P.D.; Tognazzo S.; Pildava S.; Smailyte G.; Calleja N.; Micallef R.; Johannesen T.B.; Rachtan J.; Gozdz S.; Me zyk R.; Baszczyk J.; Kepska K.; Bielska-Lasota M.; Forjaz de Lacerda G.; Bento M.J.; Antunes L.; Miranda A.; Mayer-Da-silva A.; Nicula F.; Coza D.; Diba C.S.; Primic-Zakelj M.; Almar E.; Mateos A.; Errezola M.; Larranaga N.; Torrella-Ramos A.; Garcia J.M.D.; Marcos-Navarro A.I.; Marcos-Gragera R.; Vilardell L.; Sanchez M.J.; Navarro C.; Moreno-Iribas C.; Ardanaz E.; Galceran J.; Lambe M.; Khan S.; Mousavi M.; Bouchardy C.; Ess S.M.; Frick H.; Lorez M.; Ess S.M.; Herrmann C.; Bordoni A.; Spitale A.; Konzelmann I.; Visser O.; Lemmens V.; Coleman M.; Allemani C.; Rachet B.; Verne J.; Easey N.; Lawrence G.; Moran T.; Rashbass J.; Roche M.; Wilkinson J.; Gavin A.; Fitzpatrick D.; Brewster D.H.; Huws D.W.; White C.
  • Anno di pubblicazione: 2015
  • Tipologia: Articolo in rivista
  • OA Link:


Background Overall survival after cancer is frequently used when assessing a health care service's performance as a whole. It is mainly used by the public, politicians and the media, and is often dismissed by clinicians because of the heterogeneous mix of different cancers, risk factors and treatment modalities. Here we give survival details for all cancers combined in Europe, correlating it with economic variables to suggest reasons for differences. Methods We computed age and cancer site case-mix standardised relative survival for all cancers combined (ACRS) for 29 countries participating in the EUROCARE-5 project with data on more than 7.5 million cancer cases from 87 population-based cancer registries, using complete and period approach. Results Denmark, United Kingdom (UK) and Eastern European countries had lower survival than neighbouring countries. Five-year ACRS has been increasing throughout Europe, and substantial increases, between 1999-2001 and 2005-2007, have been achieved in countries where survival was lower in the past. Five-year ACRS for men and women are positively correlated with macro-economic variables like the Gross Domestic Product (GDP) and Total National Expenditure on Health (TNEH) (R 2 about 70%). Countries with recent larger increases in GDP and TNEH had greater increases in cancer survival. Conclusions ACRS serves to compare all cancer survival in Europe taking account of the geographical variability in case-mixes. The EUROCARE-5 data on ACRS confirm previous EUROCARE findings. Survival appears to correlate with macro-economic determinants, particularly with investments in the health care system.